There are 101 resources available
Should we really use PD-L1 as a selection driver in cervical cancer?
Presenter: Bradley Monk
Session: Biomarkers in clinical practice and future perspective for gynaecological cancers
Resources:
Slides
Webcast
MMR status, TMB or both: How to identify endometrial cancer patients who benefit the most from immunotherapy
Presenter: Vicky Makker
Session: Biomarkers in clinical practice and future perspective for gynaecological cancers
Resources:
Webcast
Digging into molecular characterization of high-grade ovarian cancer: BRCA, HRD and beyond
Presenter: Nicole Concin
Session: Biomarkers in clinical practice and future perspective for gynaecological cancers
Resources:
Slides
Webcast
The role of MAPK pathway to select therapy in low-grade ovarian cancer
Presenter: Susana Banerjee
Session: Biomarkers in clinical practice and future perspective for gynaecological cancers
Resources:
Slides
Webcast
Live Q&A
Presenter: Bradley Monk
Session: Biomarkers in clinical practice and future perspective for gynaecological cancers
Resources:
Webcast
Introduction
Presenter: Mansoor Raza Mirza
Session: Management of endometrial cancer in the molecular era
Resources:
Slides
Webcast
Recent developments in surgery for early-stage disease
Presenter: Christian Marth
Session: Management of endometrial cancer in the molecular era
Resources:
Slides
Webcast
Recent developments in adjuvant treatment
Presenter: Carien Creutzberg
Session: Management of endometrial cancer in the molecular era
Resources:
Slides
Webcast
New treatment options for advanced and metastatic disease
Presenter: Alexandra Leary
Session: Management of endometrial cancer in the molecular era
Resources:
Slides
Webcast
Live Q&A
Presenter: Carien Creutzberg
Session: Management of endometrial cancer in the molecular era
Resources:
Webcast